Class information for:
Level 1: RESISTANT HYPERTENSION//RENAL DENERVATION//RENAL SYMPATHETIC DENERVATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8511 1177 38.4 80%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
694 12327 ROSTRAL VENTROLATERAL MEDULLA//RESISTANT HYPERTENSION//RENAL DENERVATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RESISTANT HYPERTENSION Author keyword 205 54% 23% 265
2 RENAL DENERVATION Author keyword 194 57% 19% 228
3 RENAL SYMPATHETIC DENERVATION Author keyword 61 67% 5% 55
4 TREATMENT RESISTANT HYPERTENSION Author keyword 33 83% 2% 19
5 BAROREFLEX ACTIVATION THERAPY Author keyword 27 92% 1% 11
6 ETAMICASTAT Author keyword 20 100% 1% 9
7 SYMPLICITY Author keyword 18 83% 1% 10
8 CAROTID BARORECEPTOR STIMULATION Author keyword 18 89% 1% 8
9 NEUROVASC HYPERTENS KIDNEY DIS Address 14 47% 2% 22
10 HYPERTENSION RESISTANT TO CONVENTIONAL THERAPY Author keyword 13 71% 1% 10

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RESISTANT HYPERTENSION 205 54% 23% 265 Search RESISTANT+HYPERTENSION Search RESISTANT+HYPERTENSION
2 RENAL DENERVATION 194 57% 19% 228 Search RENAL+DENERVATION Search RENAL+DENERVATION
3 RENAL SYMPATHETIC DENERVATION 61 67% 5% 55 Search RENAL+SYMPATHETIC+DENERVATION Search RENAL+SYMPATHETIC+DENERVATION
4 TREATMENT RESISTANT HYPERTENSION 33 83% 2% 19 Search TREATMENT+RESISTANT+HYPERTENSION Search TREATMENT+RESISTANT+HYPERTENSION
5 BAROREFLEX ACTIVATION THERAPY 27 92% 1% 11 Search BAROREFLEX+ACTIVATION+THERAPY Search BAROREFLEX+ACTIVATION+THERAPY
6 ETAMICASTAT 20 100% 1% 9 Search ETAMICASTAT Search ETAMICASTAT
7 SYMPLICITY 18 83% 1% 10 Search SYMPLICITY Search SYMPLICITY
8 CAROTID BARORECEPTOR STIMULATION 18 89% 1% 8 Search CAROTID+BARORECEPTOR+STIMULATION Search CAROTID+BARORECEPTOR+STIMULATION
9 HYPERTENSION RESISTANT TO CONVENTIONAL THERAPY 13 71% 1% 10 Search HYPERTENSION+RESISTANT+TO+CONVENTIONAL+THERAPY Search HYPERTENSION+RESISTANT+TO+CONVENTIONAL+THERAPY
10 REFRACTORY HYPERTENSION 8 35% 2% 19 Search REFRACTORY+HYPERTENSION Search REFRACTORY+HYPERTENSION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BAROREFLEX ACTIVATION THERAPY 96 83% 5% 54
2 RHEOS PIVOTAL TRIAL 94 89% 4% 42
3 TREATMENT RESISTANT HYPERTENSION 85 66% 7% 79
4 RESISTANT HYPERTENSION 66 24% 20% 238
5 SYMPATHETIC DENERVATION 53 31% 12% 145
6 REFRACTORY HYPERTENSION 49 56% 5% 59
7 ANGIOTENSIN HYPERTENSION 48 91% 2% 20
8 RENAL SYMPATHETIC DENERVATION 38 45% 5% 64
9 MULTICENTER FEASIBILITY 32 85% 1% 17
10 PROLONGED ACTIVATION 32 57% 3% 38

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings 2014 19 15 73%
International Expert Consensus Statement Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension 2013 32 53 81%
The Baroreflex as a Long-Term Controller of Arterial Pressure 2015 4 56 63%
Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial 2012 111 27 52%
Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive Populations 2015 2 33 73%
Design Considerations for Clinical Trials of Autonomic Modulation Therapies Targeting Hypertension and Heart Failure 2015 3 73 53%
Beyond Blood Pressure: Percutaneous Renal Denervation for the Management of Sympathetic Hyperactivity and Associated Disease States 2015 1 38 92%
Updated ESH position paper on interventional therapy of resistant hypertension 2013 19 47 68%
Renal Denervation as a Therapeutic Approach for Hypertension Novel Implications for an Old Concept 2009 94 49 65%
Renal Sympathetic Denervation for Treatment of Resistant Hypertension: A Systematic Review 2013 10 25 96%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROVASC HYPERTENS KIDNEY DIS 14 47% 1.9% 22
2 MONASH CARDIOVASC EDUC THER EUT 4 26% 1.1% 13
3 KLIN INNERE MED KARDIOL ANGIOL INTERNIST INTENS 4 18% 1.7% 20
4 POLE CARDIOVASC 4 41% 0.6% 7
5 HYPERTENS DIABETOL 3 13% 1.9% 22
6 VASC BIOL HYPERTENS PROGRAM 3 12% 2.0% 23
7 DIPARTIMENTO MED CLIN PREVENZ BIOTECNOL SANITAI 3 60% 0.3% 3
8 ASH COMPREHENS HYPERTENS 3 23% 0.8% 10
9 BAKER HEART CARDIOVASC MED 2 67% 0.2% 2
10 CIC1418 2 67% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000177280 MUSCLE SYMPATHETIC NERVE ACTIVITY//SAHLGREN//EXERCISE SCI HLTH PHYS EDUC
2 0.0000175561 RENALASE//PROXIMAL TUBULAR TRANSPORT//RENAL DOPAMINE SYSTEM
3 0.0000173318 AFFERENT RENAL NERVES//AFFERENT RENAL NERVE ACTIVITY//RENAL CHEMORECEPTORS
4 0.0000124486 BAROREFLEX FAILURE//NEUROVASCULAR COMPRESSION//CAROTID SINUS DENERVATION
5 0.0000109938 SPECIALIZED HYPERTENS GENET//HYPERTENS GENET SPECIALIZED//BIOMED IL 236
6 0.0000103620 CARDIAC SYMPATHETIC AFFERENT REFLEX//ROSTRAL VENTROLATERAL MEDULLA//ADV CARDIOVASC REGULAT THER EUT
7 0.0000102483 REDUCED RENAL PERFUSION PRESSURE//PRESSURE ESCAPE//JR GRP 2
8 0.0000090106 CAROTID SINUS BAROREFLEX//WHITE NOISE TECHNIQUE//CARDIOVASC DYNAM
9 0.0000076402 UNITE PHYSIOL INTEGREE//ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST//PATHOL VASC
10 0.0000069172 AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY